Fig. 3From: Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modificationBioinformatic analysis of ZNF132. a A total of 6% (58/960) of GC cases exhibited ZNF132 alteration. b OS analysis of BC patients with and without ZNF132 alteration. c Potential biological processes and biological pathways in BC were identified by GSEA analysis. d ZNF132 expression was negatively correlated with the cell cycle and glycolysis pathwayBack to article page